Skip to main content

Table 1 Population characteristics

From: Impairment of cardiac metabolism and sympathetic innervation after aneurysmal subarachnoid hemorrhage: a nuclear medicine imaging study

Age, years (mean ± SD)

61 ± 12

Female sex, n (%)

22 (73%)

BMI, kg/m2(mean ± SD)

24.3 ± 2.7

Past medical history, n (%):

 

Active smoking

14 (47%)

Arterial hypertension

9 (30%)

Dyslipidemia

4 (13%)

Obesity (BMI >30 kg/m2)

1 (3%)

Diabetes mellitus

0 (0%)

Pheochromocytoma

0 (0%)

Thyroid disease (substituted hypothyroidism)

1 (3%)

Renal disease

0 (0%)

Liver disease

0 (0%)

Fisher grade (1/2/3/4), n (%)

0 (0%)/3 (10%)/9 (30%)/18 (60%)

WFNS score (1/2/3/4/5), n (%)

12 (40%)/6 (20%)/3 (10%)/0 (0%)/9 (30%)

Aneurysm position, n (%)

 

ICA

7 (24%)

MCA

10 (33%)

AComA/ACA

10 (33%)

VA/BA

1 (3%)

PCA/PComA

2 (7%)

Aneurysm treatment

 

Coiled, n (%)

27 (90%)

Craniotomy, n (%)

3 (10%)

Day of treatment, (mean ± SD)

1.9 ± 0.7

ICU period, n (%):

 

Vasospasm

14 (47%)

Delayed cerebral ischemia

8 (27%)

Re-bleeding

4 (13%)

Hydrocephalus (derivated)

16 (53%)

Tracheostomy

11 (37%)

ICU length of stay, day (mean ± SD)

16 ± 8

Level of glucose just before 18 F-FDG PET

139 ± 4

 (mg/dl, mean ± SD)

 
  1. 18F-FDG PET, 18F-fluorodesoxyglucose positron emission tomography; ACA, anterior cerebral artery; AcomA, anterior communicating artery; BA, basilar artery; BMI, body mass index; ICA, internal carotid artery; ICU, intensive care unit; MCA, middle cerebral artery; PCA, posterior cerebral artery; PComA, posterior communicating artery; SD, standard deviation; VA, vertebral artery; WFNS, World Federation of Neurosurgical Societies.